Patrick F. Cua
Directeur Général chez Glytec LLC
Profil
Patrick F.
Cua is the founder of Healthstar Global LLC, which was founded in 2008.
He holds the title of President & Chief Executive Officer at Healthstar Global LLC.
Mr. Cua's current job is Chief Executive Officer at Glytec LLC since 2017.
He is also the Chairman at BioIQ, Inc. Mr. Cua's former job was as a Principal at C.
R.
Bard, Inc. (New Jersey).
Postes actifs de Patrick F. Cua
| Sociétés | Poste | Début |
|---|---|---|
BioIQ, Inc.
 BioIQ, Inc. Packaged SoftwareTechnology Services BioIQ, Inc. develops and markets health screening and medical diagnostic platforms. It offers health improvement technologies, with focus on optimizing investments in corporate health and wellness programs. The firm's technology platform features the Dimensions, Axis, Ecosystem and Advisor components, serving as foundation for outcome-based wellness, performance measurement, population stratification and assignment of targeted health-improvement solutions based on each participant's actual risk. The company was founded by Justin J. Bellante and Raja Jindal in 2005 and is headquartered in Atlanta, GA. | Président | - |
Healthstar Global LLC
 Healthstar Global LLC Other Consumer ServicesConsumer Services Healthstar Global LLC provides training, recruiting, advisory, and distribution services. The company was founded by Patrick F. Cua is headquartered in Kennesaw, GA. | Directeur Général | 01/01/2008 |
Glytec LLC
 Glytec LLC Packaged SoftwareTechnology Services Part of Aseko, Inc., Glytec LLC is a healthcare provider company that specializes in improving the quality and cost of care for diabetes patients. The company, founded in 2006 by Robby Booth, is based in Waltham, MA, and has Edmond L. Furlong as its CEO since 2018. Glytec's FDA-cleared titration software and proprietary algorithms deliver personalized diabetes treatment recommendations across the continuum of care, from hospital to home. The company's eGlycemic Management System (eGMS) is an EHR-integrated cloud-based software solution that supports safe and effective glycemic management and insulin dosing. Glytec supports the transition from sliding scale to basal bolus insulin for standardization of insulin therapy across critical and non-critical care settings. The safety and efficacy of Glytec's solutions have been validated by several dozen studies published in medical journals and presented at scientific conferences. | Directeur Général | 04/01/2024 |
Anciens postes connus de Patrick F. Cua
| Sociétés | Poste | Fin |
|---|---|---|
| C.R. BARD | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
BioIQ, Inc.
BioIQ, Inc. Packaged SoftwareTechnology Services BioIQ, Inc. develops and markets health screening and medical diagnostic platforms. It offers health improvement technologies, with focus on optimizing investments in corporate health and wellness programs. The firm's technology platform features the Dimensions, Axis, Ecosystem and Advisor components, serving as foundation for outcome-based wellness, performance measurement, population stratification and assignment of targeted health-improvement solutions based on each participant's actual risk. The company was founded by Justin J. Bellante and Raja Jindal in 2005 and is headquartered in Atlanta, GA. | Technology Services |
Healthstar Global LLC
Healthstar Global LLC Other Consumer ServicesConsumer Services Healthstar Global LLC provides training, recruiting, advisory, and distribution services. The company was founded by Patrick F. Cua is headquartered in Kennesaw, GA. | Consumer Services |
C. R. Bard, Inc. (New Jersey)
 C. R. Bard, Inc. (New Jersey) Medical SpecialtiesHealth Technology C. R. Bard, Inc. engages in designing, development, manufacturing, packaging, distribution, and sales of medical, surgical, diagnostic, and patient care devices. It sells its products to hospitals, individual healthcare professionals, extended care facilities, and alternate site facilities. The company was founded by Charles Russell Bard in 1907 and is headquartered in Franklin Lakes, NJ. | Health Technology |
Glytec LLC
Glytec LLC Packaged SoftwareTechnology Services Part of Aseko, Inc., Glytec LLC is a healthcare provider company that specializes in improving the quality and cost of care for diabetes patients. The company, founded in 2006 by Robby Booth, is based in Waltham, MA, and has Edmond L. Furlong as its CEO since 2018. Glytec's FDA-cleared titration software and proprietary algorithms deliver personalized diabetes treatment recommendations across the continuum of care, from hospital to home. The company's eGlycemic Management System (eGMS) is an EHR-integrated cloud-based software solution that supports safe and effective glycemic management and insulin dosing. Glytec supports the transition from sliding scale to basal bolus insulin for standardization of insulin therapy across critical and non-critical care settings. The safety and efficacy of Glytec's solutions have been validated by several dozen studies published in medical journals and presented at scientific conferences. | Technology Services |
